FULC · Fulcrum Therapeutics, Inc.

$3.83 +0.00 (+0.00%)

Market Cap

$292.22M

76.30M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-17	2026-08-16
8-K	2026-08-10	2026-08-07
10-Q	2026-07-30	2026-06-30
8-K	2026-06-25	2026-06-24
8-K	2026-06-11	2026-06-05
8-K	2026-06-04	2026-05-31
8-K	2026-06-01	—
DEF 14A	2026-04-30	2026-06-24
10-Q	2026-04-27	2026-03-31
8-K	2026-04-27	2026-04-23
8-K	2026-02-24	—
10-K	2026-02-24	2025-12-31
8-K	2026-01-12	—
8-K	2025-12-11	2025-12-10
8-K	2025-12-08	—
8-K	2025-10-29	—
10-Q	2025-10-29	2025-09-30
8-K	2025-08-28	—
10-Q	2025-07-29	2025-06-30
8-K	2025-07-29	—
8-K	2025-06-27	2025-06-26
8-K	2025-05-01	—
10-Q	2025-05-01	2025-03-31
DEF 14A	2025-04-30	2025-04-25
8-K	2025-03-04	2025-02-26
10-K	2025-02-25	2024-12-31
8-K	2025-02-25	—
8-K	2025-01-13	—
8-K	2024-12-23	2024-12-18
8-K	2024-11-13	—
10-Q	2024-11-13	2024-09-30
8-K	2024-11-12	—
8-K	2024-09-24	—
8-K	2024-09-12	—
8-K	2024-08-22	2024-08-21
8-K	2024-07-31	—
10-Q	2024-07-31	2024-06-30
8-K	2024-06-17	—
8-K	2024-05-13	2024-05-11
10-Q	2024-05-13	2024-03-31
DEF 14A	2024-04-19	2024-06-17
10-K	2024-02-27	2023-12-31
8-K	2024-02-27	—
8-K	2023-11-07	—
10-Q	2023-11-07	2023-09-30
8-K	2023-10-02	2023-09-28
8-K	2023-08-22	—
8-K	2023-08-03	2023-08-02
10-Q	2023-08-03	2023-06-30
8-K	2023-07-10	2023-07-05

Showing 1–50 of 116 filings

Key facts CIK 1680581 CUSIP 359616109 13F (30d) 143 filings 139 filers Visit website Investor relations